Add like
Add dislike
Add to saved papers

Descriptive outcomes of the American Lung Association of Ohio hypnotherapy smoking cessation program.

Hypnosis smoking cessation treatment is one type of program available to smokers. This paper describes a large randomly selected sample from such a program, which has not been previously reported. During 1997, 2,810 smokers participated in single-session, group hypnotherapy smoking cessation programs sponsored by the American Lung Association of Ohio. A randomly selected sample of 452 participants completed telephone interviews 5 to 15 months after attending a treatment session. Twenty-two percent of participants (n = 101) reported not smoking during the month prior to the interview. Use of other smoking cessation strategies since the treatment session were assessed. Interestingly, only 20% of participants who used pharmaceutical products to assist with smoking cessation took them for the recommended treatment duration. Hypnotherapy smoking cessation treatment offers an alternative cessation method, which may meet the unique needs of certain individuals.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app